Davide Serrano, MD; Sara Gandini, PhD; Parjhitham Thomas, MD; et al.
This randomized clinical trial compares exemestane, 25 mg, given once daily, 3 times weekly, and once weekly for the treatment of estrogen receptor–positive breast cancer in postmenopausal women prior to surgery.